A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: production of the human T cell receptor Vβ5.3 in Escherichia coli

Abstract

A series of vectors has been constructed to express the human T cell receptor Vβ5.3 under the control of the hybrid trc promoter in Escherichia coli. Transcriptional induction of the trc promoter was achieved chemically by using isopropyl β- d-thiogalactopyranoside (IPTG) in a bacterial strain that harbors the lacI q gene, or thermally by using the mutant laclts gene that encodes a temperature-sensitive lac repressor [Bukrinsky et al. (1988) Multicopy expression vector based on temperature-regulated lac repressor: expression of human immunodeficiency virus env gene in Escherichia coli. Gene 70, 415–417]. Several of the plasmids tested also contain the E. coli heat-stable enterotoxin II (STII) signal sequence for protein secretion. In addition, the gene 10 leader sequence from bacteriophage T7 and a minicistron localized upstream of the Vβ5.3 coding sequence were tested for their potential effect on protein production. These elements increased protein yield two-fold when transcription was induced by IPTG, but had no detectable effect on protein yield when transcription was induced thermally. The highest protein yield was obtained when Vβ5.3 was expressed either from plasmid pKB containing the STII signal in strain LJ24, or from plasmid pKBi that lacks the signal sequence, in the protease deficient strain SG21173 ( lon, htpR, clp). Both plasmids contain the laclts gene, the trc promoter, the two transcription terminators of the rrnB operon, and a tetracycline selection marker. Production of Vβ5.3 using pKBi-Vβ5.3 in strain SG21173 in a 5-liter fermenter under controlled growth conditions yielded over 25 mg Vβ5.3/liter culture. Conversion of the laclts to the lacI qts gene yielded vector pKBiq-Vβ5.3 which exhibits complete repression of the trc promoter at 30°C. This stringent regulation of the thermally inducible trc promoter, the elimination of IPTG, the inclusion of the tetracycline resistance gene, and the high level of protein yield should render this expression system broadly useful for the high level production of heterologous proteins in E. coli, for both basic research and human therapeutic applications.